Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Fortress Biotech, Inc.. Director active across 4 companies, notably Mustang Bio, INC.. Aggregated, 24 reports have been recorded. Split: 1 buy · 1 sell. Total volume traded: €395k. History available since 31 December 2022. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Fortress Biotech, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
90,909 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-000998:0
24 of 24 declarations
About Fortress Biotech, Inc.
Fortress Biotech, Inc. is a declarant with 24 filings in total. Among the recent filings tracked from 2023-01-04 to 2026-01-06, the stated transaction nature is Attribution, with buys of EUR 281604 and sells of EUR 113373, mainly related to Avenue Therapeutics, INC. and Checkpoint Therapeutics, Inc.